Skip to content

Clinical trials

Carcinoma, Transitional Cell trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Country / region: Denmark Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20141
20151
20161
20173
20182
20192
20211
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation3
Dr Anders Ullén2
Eli Lilly and Company2
Merck Sharp & Dohme LLC2
Bayer1
Bristol-Myers Squibb1
Herlev Hospital1
Kinnate Biopharma1
Pfizer1
Rainier Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell16
Urinary Bladder Neoplasms8
Neoplasm Metastasis4
Urethral Neoplasms3
Ureteral Neoplasms2
Acrocephalosyndactylia1
Anus Neoplasms1
Basal Cell Carcinoma1
Breast Neoplasms1
Carcinoma, Merkel Cell1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.